Profile | GDS5420 / AFFX-PheX-M_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1005.15 | 79 |
GSM1296119 | B_lesional_pre-dose | 414.93 | 65 |
GSM1296076 | C_lesional_pre-dose | 385.44 | 64 |
GSM1296092 | D_lesional_pre-dose | 493.15 | 68 |
GSM1296103 | E_lesional_pre-dose | 1166.02 | 81 |
GSM1296078 | F_lesional_pre-dose | 386.11 | 65 |
GSM1296107 | G_lesional_pre-dose | 678.76 | 73 |
GSM1296109 | H_lesional_pre-dose | 1098.62 | 81 |
GSM1296080 | I_lesional_pre-dose | 1708.88 | 87 |
GSM1296090 | J_lesional_pre-dose | 403.84 | 65 |
GSM1296074 | K_lesional_pre-dose | 311.5 | 61 |
GSM1296111 | L_lesional_pre-dose | 602.57 | 71 |
GSM1296099 | M_lesional_pre-dose | 626.96 | 71 |
GSM1296086 | O_lesional_pre-dose | 510.76 | 68 |
GSM1296117 | P_lesional_pre-dose | 482.91 | 67 |
GSM1296113 | Q_lesional_pre-dose | 630.52 | 72 |
GSM1296096 | R_lesional_pre-dose | 587.57 | 70 |
GSM1296105 | S_lesional_pre-dose | 768.28 | 75 |
GSM1296098 | T_lesional_pre-dose | 1425.07 | 85 |
GSM1296101 | U_lesional_pre-dose | 898.89 | 77 |
GSM1296121 | V_lesional_pre-dose | 514.92 | 68 |
GSM1296088 | W_lesional_pre-dose | 999.32 | 79 |
GSM1296082 | X_lesional_pre-dose | 439.79 | 66 |
GSM1296115 | Y_lesional_pre-dose | 559.7 | 70 |
GSM1296084 | Z_lesional_pre-dose | 969.79 | 79 |
GSM1296072 | B_lesional_day8 | 362.89 | 62 |
GSM1296069 | L_lesional_day8 | 563.5 | 69 |
GSM1296071 | P_lesional_day8 | 722.52 | 74 |
GSM1296070 | Y_lesional_day8 | 581.74 | 70 |
GSM1296073 | V_lesional_day8 | 387.63 | 64 |
GSM1296034 | A_lesional_day15 | 2356.12 | 92 |
GSM1296041 | G_lesional_day15 | 680.11 | 73 |
GSM1296035 | R_lesional_day15 | 615.35 | 71 |
GSM1296038 | U_lesional_day15 | 571.4 | 70 |
GSM1296047 | B_lesional_day15 | 532.9 | 69 |
GSM1296039 | E_lesional_day15 | 351.86 | 62 |
GSM1296042 | H_lesional_day15 | 669.66 | 73 |
GSM1296043 | L_lesional_day15 | 780.59 | 75 |
GSM1296037 | M_lesional_day15 | 883.6 | 77 |
GSM1296046 | P_lesional_day15 | 568.32 | 69 |
GSM1296044 | Q_lesional_day15 | 714.63 | 74 |
GSM1296045 | Y_lesional_day15 | 563.01 | 69 |
GSM1296025 | C_lesional_day15 | 1241.25 | 82 |
GSM1296033 | D_lesional_day15 | 697.96 | 73 |
GSM1296027 | I_lesional_day15 | 665.3 | 72 |
GSM1296032 | J_lesional_day15 | 1423.46 | 85 |
GSM1296024 | K_lesional_day15 | 834.85 | 76 |
GSM1296031 | W_lesional_day15 | 1411.16 | 85 |
GSM1296028 | X_lesional_day15 | 848.03 | 76 |
GSM1296029 | Z_lesional_day15 | 1263.8 | 83 |
GSM1296026 | F_lesional_day15 | 521.21 | 69 |
GSM1296030 | O_lesional_day15 | 726.56 | 74 |
GSM1296040 | S_lesional_day15 | 1280.9 | 83 |
GSM1296036 | T_lesional_day15 | 1417.78 | 85 |
GSM1296048 | V_lesional_day15 | 392.12 | 64 |
GSM1296059 | A_lesional_day43 | 734.08 | 74 |
GSM1296066 | G_lesional_day43 | 628.71 | 72 |
GSM1296060 | R_lesional_day43 | 607.38 | 71 |
GSM1296063 | U_lesional_day43 | 393.56 | 64 |
GSM1296064 | E_lesional_day43 | 432.83 | 66 |
GSM1296067 | H_lesional_day43 | 732.35 | 74 |
GSM1296062 | M_lesional_day43 | 1200.19 | 82 |
GSM1296068 | Q_lesional_day43 | 637.61 | 72 |
GSM1296050 | C_lesional_day43 | 591.5 | 71 |
GSM1296057 | D_lesional_day43 | 561.39 | 69 |
GSM1296052 | I_lesional_day43 | 642.93 | 72 |
GSM1296054 | J_lesional_day43 | 1539.26 | 86 |
GSM1296049 | K_lesional_day43 | 938.76 | 78 |
GSM1296055 | W_lesional_day43 | 849.78 | 76 |
GSM1296053 | X_lesional_day43 | 1435.46 | 85 |
GSM1296058 | Z_lesional_day43 | 671.46 | 72 |
GSM1296051 | F_lesional_day43 | 463.03 | 67 |
GSM1296056 | O_lesional_day43 | 438.92 | 66 |
GSM1296065 | S_lesional_day43 | 434.02 | 65 |
GSM1296061 | T_lesional_day43 | 2193.85 | 91 |
GSM1296095 | A_non-lesional_pre-dose | 612.23 | 71 |
GSM1296120 | B_non-lesional_pre-dose | 671.99 | 73 |
GSM1296077 | C_non-lesional_pre-dose | 722.19 | 74 |
GSM1296093 | D_non-lesional_pre-dose | 2128.79 | 91 |
GSM1296104 | E_non-lesional_pre-dose | 563.26 | 70 |
GSM1296079 | F_non-lesional_pre-dose | 959.77 | 78 |
GSM1296108 | G_non-lesional_pre-dose | 702.27 | 73 |
GSM1296110 | H_non-lesional_pre-dose | 863.22 | 77 |
GSM1296081 | I_non-lesional_pre-dose | 3024.38 | 93 |
GSM1296091 | J_non-lesional_pre-dose | 616.67 | 71 |
GSM1296075 | K_non-lesional_pre-dose | 508.99 | 69 |
GSM1296112 | L_non-lesional_pre-dose | 758.01 | 75 |
GSM1296100 | M_non-lesional_pre-dose | 1481.34 | 85 |
GSM1296087 | O_non-lesional_pre-dose | 536.47 | 69 |
GSM1296118 | P_non-lesional_pre-dose | 902.63 | 78 |
GSM1296114 | Q_non-lesional_pre-dose | 921.69 | 78 |
GSM1296097 | R_non-lesional_pre-dose | 458.48 | 66 |
GSM1296106 | S_non-lesional_pre-dose | 734.18 | 74 |
GSM1296102 | U_non-lesional_pre-dose | 921.38 | 78 |
GSM1296122 | V_non-lesional_pre-dose | 832.93 | 76 |
GSM1296089 | W_non-lesional_pre-dose | 1272.02 | 83 |
GSM1296083 | X_non-lesional_pre-dose | 2603.22 | 92 |
GSM1296116 | Y_non-lesional_pre-dose | 763.73 | 75 |
GSM1296085 | Z_non-lesional_pre-dose | 1158.17 | 81 |